Showing results (671-680 of 1,155) with videos related to

Sort By:
Pageof 116
Arthritis and Rheumatism|April 11, 2012
Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinolLisa K Stamp, William J Taylor, Peter B Jones, et al.
Clinical Pharmacology and Therapeutics|July 29, 2011
Relationship between serum urate and plasma oxypurinol in the management of gout: determination of minimum plasma oxypurinol concentration to achieve a target serum urate levelL K Stamp, M L Barclay, J L O'Donnell, et al.
The Journal of Rheumatology|October 4, 2011
Effects of changing from oral to subcutaneous methotrexate on red blood cell methotrexate polyglutamate concentrations and disease activity in patients with rheumatoid arthritisLisa K Stamp, Murray L Barclay, John L O'Donnell, et al.
The Journal of Pathology|February 13, 2003
Fluorescence lifetime imaging of unstained tissues: early results in human breast cancerPaul J Tadrous, Jan Siegel, Paul M W French, et al.
British Journal of Cancer|October 1, 1995
MDM2 overexpression is rare in ovarian carcinoma irrespective of TP53 mutation statusW D Foulkes, G W Stamp, S Afzal, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|July 1, 1996
The immunomodulatory effects of antibiotics: in vitro and ex vivo investigations of 21 substances by means of the lymphocyte transformation testS Schubert, B H Andresen, V Bähr, et al.
Journal of the National Cancer Institute|July 1, 1992
Promotion of aberrant crypt foci and cancer in rat colon by thermolyzed proteinX M Zhang, D Stamp, S Minkin, et al.
Anesthesia and Analgesia|November 21, 2024
Outcomes Associated with a Patient Blood Management Program in Major Obstetric Hemorrhage: A Retrospective Cohort StudyTarek Ansari, Saleema Wani, Axel Hofmann, et al.
Clinical Pharmacokinetics|March 14, 2013
A population pharmacokinetic model for low-dose methotrexate and its polyglutamated metabolites in red blood cellsJulia Korell, Lisa K Stamp, Murray L Barclay, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2007
Raf signaling but not the ERK effector SAP-1 is required for regulatory T cell developmentJane E Willoughby, Patrick S Costello, Robert H Nicolas, et al.
Pageof 116